|
|
Volumn 331, Issue 6024, 2011, Pages 1505-
|
|
Candidate radiation drugs inch forward
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2A2;
ANTIBODY;
CBLB 502;
EX RAD;
GRANULOCYTE COLONY STIMULATING FACTOR;
INTERLEUKIN 6;
POTASSIUM IODIDE;
RADIOPROTECTIVE AGENT;
REACTIVE OXYGEN METABOLITE;
UNCLASSIFIED DRUG;
(E) 4 CARBOXYSTYRYL 4 CHLOROBENZYLSULFONE, SODIUM SALT;
(E)-4-CARBOXYSTYRYL-4-CHLOROBENZYLSULFONE, SODIUM SALT;
CBLB502;
CERAMIDE;
PEPTIDE;
SULFONAMIDE;
CANCER;
COMMERCIALIZATION;
PHARMACEUTICAL INDUSTRY;
POTASSIUM;
PUBLIC HEALTH;
RADIATION EXPOSURE;
DNA DAMAGE;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
RADIATION EXPOSURE;
RADIATION PROTECTION;
RADIATION SICKNESS;
SHORT SURVEY;
THYROID CANCER;
ANIMAL;
DRUG APPROVAL;
DRUG DEVELOPMENT;
FOOD AND DRUG ADMINISTRATION;
IMMUNOLOGY;
NOTE;
RADIATION INJURY;
UNITED STATES;
JAPAN;
ANIMALS;
ANTIBODIES;
CERAMIDES;
DRUG APPROVAL;
DRUG DISCOVERY;
HUMANS;
PEPTIDES;
RADIATION INJURIES;
RADIATION-PROTECTIVE AGENTS;
SULFONAMIDES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79953143098
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.331.6024.1505 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|
